We previously have shown that treatment with the telomerase substrate nucleoside precursor 6-thio-dG attenuates tumor growth of telomerase-positive neuroblastoma cell lines, both in vitro and in vivo, but not that of ALT-positive tumors [4]. The gene discussed is GPT; the disease is neoplasm.